Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

USPH vs ACHC vs SEM vs SGRY vs ENSG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
USPH
U.S. Physical Therapy, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$897M
5Y Perf.-20.4%
ACHC
Acadia Healthcare Company, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$2.25B
5Y Perf.-14.5%
SEM
Select Medical Holdings Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$2.04B
5Y Perf.+89.2%
SGRY
Surgery Partners, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.87B
5Y Perf.+6.8%
ENSG
The Ensign Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$10.18B
5Y Perf.+298.7%

USPH vs ACHC vs SEM vs SGRY vs ENSG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
USPH logoUSPH
ACHC logoACHC
SEM logoSEM
SGRY logoSGRY
ENSG logoENSG
IndustryMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$897M$2.25B$2.04B$1.87B$10.18B
Revenue (TTM)$695M$3.37B$5.52B$3.34B$5.27B
Net Income (TTM)$11M$-1.11B$134M$-76M$363M
Gross Margin22.0%56.2%10.6%22.8%15.2%
Operating Margin12.2%11.7%5.8%11.8%8.5%
Forward P/E20.6x16.4x13.1x38.0x23.2x
Total Debt$426M$2.65B$3.70B$4.02B$4.15B
Cash & Equiv.$36M$133M$27M$240M$504M

USPH vs ACHC vs SEM vs SGRY vs ENSGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

USPH
ACHC
SEM
SGRY
ENSG
StockMay 20May 26Return
U.S. Physical Thera… (USPH)10079.6-20.4%
Acadia Healthcare C… (ACHC)10085.5-14.5%
Select Medical Hold… (SEM)100189.2+89.2%
Surgery Partners, I… (SGRY)100106.8+6.8%
The Ensign Group, I… (ENSG)100398.7+298.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: USPH vs ACHC vs SEM vs SGRY vs ENSG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ENSG leads in 5 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. U.S. Physical Therapy, Inc. is the stronger pick specifically for dividend income and shareholder returns. SEM also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
USPH
U.S. Physical Therapy, Inc.
The Income Pick

USPH is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 5 yrs, beta 0.93, yield 3.1%
  • 3.1% yield, 5-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend)
Best for: income & stability
ACHC
Acadia Healthcare Company, Inc.
The Healthcare Pick

ACHC lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
SEM
Select Medical Holdings Corporation
The Value Play

SEM ranks third and is worth considering specifically for value.

  • Lower P/E (13.1x vs 23.2x)
Best for: value
SGRY
Surgery Partners, Inc.
The Healthcare Pick

Among these 5 stocks, SGRY doesn't own a clear edge in any measured category.

Best for: healthcare exposure
ENSG
The Ensign Group, Inc.
The Growth Play

ENSG carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 18.7%, EPS growth 14.1%, 3Y rev CAGR 18.7%
  • 7.5% 10Y total return vs SEM's 158.5%
  • Lower volatility, beta 0.42, current ratio 1.42x
  • Beta 0.42, yield 0.1%, current ratio 1.42x
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthENSG logoENSG18.7% revenue growth vs ACHC's 5.0%
ValueSEM logoSEMLower P/E (13.1x vs 23.2x)
Quality / MarginsENSG logoENSG6.9% margin vs ACHC's -32.8%
Stability / SafetyENSG logoENSGBeta 0.42 vs SGRY's 1.04
DividendsUSPH logoUSPH3.1% yield, 5-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend)
Momentum (1Y)ENSG logoENSG+27.5% vs SGRY's -38.2%
Efficiency (ROA)ENSG logoENSG6.8% ROA vs ACHC's -18.6%, ROIC 7.0% vs 5.9%

USPH vs ACHC vs SEM vs SGRY vs ENSG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

USPHU.S. Physical Therapy, Inc.
FY 2025
Net Patient Revenues
83.3%$650M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
16.7%$131M
ACHCAcadia Healthcare Company, Inc.
FY 2025
United States Facilities
100.0%$3.3B
SEMSelect Medical Holdings Corporation
FY 2025
Health Care, Patient Service, Non-Medicare
61.5%$3.4B
Health Care, Patient Service, Medicare
28.6%$1.6B
Service, Other
9.9%$538M
SGRYSurgery Partners, Inc.
FY 2025
Healthcare Organization, Patient Service
49.4%$3.2B
Private Insurance
25.8%$1.7B
Government Revenue
21.1%$1.4B
Self-Pay Revenue
1.3%$88M
Other Services
1.3%$82M
Other Patient Service Revenue Sources
1.1%$71M
ENSGThe Ensign Group, Inc.
FY 2025
Skilled Services Segment
97.4%$4.8B
Standard Bearer Segment
2.6%$127M

USPH vs ACHC vs SEM vs SGRY vs ENSG — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLENSGLAGGINGSGRY

Income & Cash Flow (Last 12 Months)

ENSG leads this category, winning 3 of 6 comparable metrics.

SEM is the larger business by revenue, generating $5.5B annually — 7.9x USPH's $695M. ENSG is the more profitable business, keeping 6.9% of every revenue dollar as net income compared to ACHC's -32.8%. On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricUSPH logoUSPHU.S. Physical The…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…SGRY logoSGRYSurgery Partners,…ENSG logoENSGThe Ensign Group,…
RevenueTrailing 12 months$695M$3.4B$5.5B$3.3B$5.3B
EBITDAEarnings before interest/tax$107M$588M$465M$572M$558M
Net IncomeAfter-tax profit$11M-$1.1B$134M-$76M$363M
Free Cash FlowCash after capex$67M-$215M$117M$208M$406M
Gross MarginGross profit ÷ Revenue+22.0%+56.2%+10.6%+22.8%+15.2%
Operating MarginEBIT ÷ Revenue+12.2%+11.7%+5.8%+11.8%+8.5%
Net MarginNet income ÷ Revenue+1.5%-32.8%+2.4%-2.3%+6.9%
FCF MarginFCF ÷ Revenue+9.6%-6.4%+2.1%+6.2%+7.7%
Rev. Growth (YoY)Latest quarter vs prior year+7.7%+7.6%+5.0%+4.5%+18.4%
EPS Growth (YoY)Latest quarter vs prior year-115.0%-49.8%-18.2%+6.7%+21.9%
ENSG leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

SEM leads this category, winning 3 of 6 comparable metrics.

At 13.9x trailing earnings, SEM trades at a 66% valuation discount to USPH's 41.5x P/E. On an enterprise value basis, ACHC's 8.3x EV/EBITDA is more attractive than ENSG's 25.7x.

MetricUSPH logoUSPHU.S. Physical The…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…SGRY logoSGRYSurgery Partners,…ENSG logoENSGThe Ensign Group,…
Market CapShares × price$897M$2.3B$2.0B$1.9B$10.2B
Enterprise ValueMkt cap + debt − cash$1.3B$4.8B$5.7B$5.7B$13.8B
Trailing P/EPrice ÷ TTM EPS41.55x-2.01x13.93x-23.46x29.85x
Forward P/EPrice ÷ next-FY EPS est.20.63x16.42x13.06x37.99x23.19x
PEG RatioP/E ÷ EPS growth rate2.16x
EV / EBITDAEnterprise value multiple12.52x8.27x12.04x10.00x25.71x
Price / SalesMarket cap ÷ Revenue1.15x0.68x0.37x0.57x2.01x
Price / BookPrice ÷ Book value/share1.16x1.04x1.00x0.52x4.59x
Price / FCFMarket cap ÷ FCF14.71x5.33x9.57x27.46x
SEM leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

ENSG leads this category, winning 5 of 8 comparable metrics.

ENSG delivers a 16.6% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-41 for ACHC. USPH carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x.

MetricUSPH logoUSPHU.S. Physical The…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…SGRY logoSGRYSurgery Partners,…ENSG logoENSGThe Ensign Group,…
ROE (TTM)Return on equity+1.4%-40.9%+6.6%-2.2%+16.6%
ROA (TTM)Return on assets+0.9%-18.6%+2.3%-0.9%+6.8%
ROICReturn on invested capital+5.6%+5.9%+4.8%+4.1%+7.0%
ROCEReturn on capital employed+7.6%+7.5%+7.0%+5.2%+10.2%
Piotroski ScoreFundamental quality 0–955555
Debt / EquityFinancial leverage0.55x1.24x1.82x1.14x1.86x
Net DebtTotal debt minus cash$390M$2.5B$3.7B$3.8B$3.7B
Cash & Equiv.Liquid assets$36M$133M$27M$240M$504M
Total DebtShort + long-term debt$426M$2.7B$3.7B$4.0B$4.2B
Interest CoverageEBIT ÷ Interest expense15.42x-5.99x4.41x1.35x88.33x
ENSG leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

ENSG leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $2,773 for SGRY. Over the past 12 months, ENSG leads with a +27.5% total return vs SGRY's -38.2%. The 3-year compound annual growth rate (CAGR) favors ENSG at 23.6% vs ACHC's -29.2% — a key indicator of consistent wealth creation.

MetricUSPH logoUSPHU.S. Physical The…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…SGRY logoSGRYSurgery Partners,…ENSG logoENSGThe Ensign Group,…
YTD ReturnYear-to-date-24.6%+71.2%+11.4%-6.2%+0.3%
1-Year ReturnPast 12 months-14.3%+1.2%+11.1%-38.2%+27.5%
3-Year ReturnCumulative with dividends-43.7%-64.5%+7.4%-59.2%+88.9%
5-Year ReturnCumulative with dividends-43.4%-61.8%-11.1%-72.3%+103.2%
10-Year ReturnCumulative with dividends+22.6%-58.5%+158.5%-0.6%+752.0%
CAGR (3Y)Annualised 3-year return-17.4%-29.2%+2.4%-25.8%+23.6%
ENSG leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — SEM and ENSG each lead in 1 of 2 comparable metrics.

ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than SGRY's 1.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SEM currently trades 96.8% from its 52-week high vs SGRY's 59.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricUSPH logoUSPHU.S. Physical The…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…SGRY logoSGRYSurgery Partners,…ENSG logoENSGThe Ensign Group,…
Beta (5Y)Sensitivity to S&P 5000.93x0.84x0.46x1.04x0.42x
52-Week HighHighest price in past year$93.50$30.20$16.99$24.18$218.00
52-Week LowLowest price in past year$58.55$11.43$11.65$11.41$133.81
% of 52W HighCurrent price vs 52-week peak+63.1%+81.0%+96.8%+59.2%+80.0%
RSI (14)Momentum oscillator 0–10046.146.260.963.323.3
Avg Volume (50D)Average daily shares traded171K3.1M2.1M1.5M358K
Evenly matched — SEM and ENSG each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — USPH and ENSG each lead in 1 of 2 comparable metrics.

Analyst consensus: USPH as "Buy", ACHC as "Buy", SEM as "Hold", SGRY as "Buy", ENSG as "Buy". Consensus price targets imply 72.9% upside for USPH (target: $102) vs -3.9% for ACHC (target: $24). For income investors, USPH offers the higher dividend yield at 3.06% vs ENSG's 0.14%.

MetricUSPH logoUSPHU.S. Physical The…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…SGRY logoSGRYSurgery Partners,…ENSG logoENSGThe Ensign Group,…
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuyBuy
Price TargetConsensus 12-month target$102.00$23.50$18.00$18.60$222.33
# AnalystsCovering analysts1225132213
Dividend YieldAnnual dividend ÷ price+3.1%+1.5%+0.1%
Dividend StreakConsecutive years of raises510012
Dividend / ShareAnnual DPS$1.80$0.25$0.24
Buyback YieldShare repurchases ÷ mkt cap+0.6%+2.2%+4.9%0.0%+0.2%
Evenly matched — USPH and ENSG each lead in 1 of 2 comparable metrics.
Key Takeaway

ENSG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SEM leads in 1 (Valuation Metrics). 2 tied.

Best OverallThe Ensign Group, Inc. (ENSG)Leads 3 of 6 categories
Loading custom metrics...

USPH vs ACHC vs SEM vs SGRY vs ENSG: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is USPH or ACHC or SEM or SGRY or ENSG a better buy right now?

For growth investors, The Ensign Group, Inc.

(ENSG) is the stronger pick with 18. 7% revenue growth year-over-year, versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). Select Medical Holdings Corporation (SEM) offers the better valuation at 13. 9x trailing P/E (13. 1x forward), making it the more compelling value choice. Analysts rate U. S. Physical Therapy, Inc. (USPH) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — USPH or ACHC or SEM or SGRY or ENSG?

On trailing P/E, Select Medical Holdings Corporation (SEM) is the cheapest at 13.

9x versus U. S. Physical Therapy, Inc. at 41. 5x. On forward P/E, Select Medical Holdings Corporation is actually cheaper at 13. 1x.

03

Which is the better long-term investment — USPH or ACHC or SEM or SGRY or ENSG?

Over the past 5 years, The Ensign Group, Inc.

(ENSG) delivered a total return of +103. 2%, compared to -72. 3% for Surgery Partners, Inc. (SGRY). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus ACHC's -58. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — USPH or ACHC or SEM or SGRY or ENSG?

By beta (market sensitivity over 5 years), The Ensign Group, Inc.

(ENSG) is the lower-risk stock at 0. 42β versus Surgery Partners, Inc. 's 1. 04β — meaning SGRY is approximately 147% more volatile than ENSG relative to the S&P 500. On balance sheet safety, U. S. Physical Therapy, Inc. (USPH) carries a lower debt/equity ratio of 55% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — USPH or ACHC or SEM or SGRY or ENSG?

By revenue growth (latest reported year), The Ensign Group, Inc.

(ENSG) is pulling ahead at 18. 7% versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). On earnings-per-share growth, the picture is similar: Surgery Partners, Inc. grew EPS 54. 1% year-over-year, compared to -537. 4% for Acadia Healthcare Company, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — USPH or ACHC or SEM or SGRY or ENSG?

The Ensign Group, Inc.

(ENSG) is the more profitable company, earning 6. 8% net margin versus -33. 3% for Acadia Healthcare Company, Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SGRY leads at 11. 8% versus 6. 1% for SEM. At the gross margin level — before operating expenses — SGRY leads at 23. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is USPH or ACHC or SEM or SGRY or ENSG more undervalued right now?

On forward earnings alone, Select Medical Holdings Corporation (SEM) trades at 13.

1x forward P/E versus 38. 0x for Surgery Partners, Inc. — 24. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USPH: 72. 9% to $102. 00.

08

Which pays a better dividend — USPH or ACHC or SEM or SGRY or ENSG?

In this comparison, USPH (3.

1% yield), SEM (1. 5% yield), ENSG (0. 1% yield) pay a dividend. ACHC, SGRY do not pay a meaningful dividend and should not be held primarily for income.

09

Is USPH or ACHC or SEM or SGRY or ENSG better for a retirement portfolio?

For long-horizon retirement investors, Select Medical Holdings Corporation (SEM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

46), 1. 5% yield, +158. 5% 10Y return). Both have compounded well over 10 years (SEM: +158. 5%, SGRY: -0. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between USPH and ACHC and SEM and SGRY and ENSG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: USPH is a small-cap high-growth stock; ACHC is a small-cap quality compounder stock; SEM is a small-cap deep-value stock; SGRY is a small-cap quality compounder stock; ENSG is a mid-cap high-growth stock. USPH, SEM pay a dividend while ACHC, SGRY, ENSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

USPH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 13%
Run This Screen
Stocks Like

ACHC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 33%
Run This Screen
Stocks Like

SEM

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.6%
Run This Screen
Stocks Like

SGRY

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 13%
Run This Screen
Stocks Like

ENSG

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform USPH and ACHC and SEM and SGRY and ENSG on the metrics below

Revenue Growth>
%
(USPH: 7.7% · ACHC: 7.6%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.